ATONCO AND ICO NANTES ANGERS: CLINICAL PARTNERS IN THE FIGHT AGAINST CANCER
ATONCO S.A.S. (‘ATONCO’) today announces that it has entered into a clinical research partnership agreement with the Institut de Cancérologie…
News
Discover our latest news, innovations and advances in alpha-immunotherapy.
📰 Filter:
-
-
ATONCO ANNOUNCES THE APPOINTMENT OF ADRIEN REYMOND AS DIRECTOR OF REGULATORY AFFAIRS AND QUALITY ASSURANCE
Atonco today announces that Adrien Reymond, PharmD, B.Eng and EMBA candidate, will lead regulatory affairs and quality. Adrien brings 15…
-
ATONCO ANNOUNCES THE APPOINTMENT OF SYLVAIN FANIER AS NEW CHAIRMAN OF ATONCO
Atonco today announces that Sylvain Fanier, MSc. EMBA, will succeed Professor Jean-François Chatal as Chairman effective March 16, 2020. Sylvain…
-
TELIX PARTNERS WITH FRENCH COMPANY ATONCO TO FIGHT BLADDER CANCER
Australian biopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX) has signed an agreement with French company ATONCO S.A.S. to study the…